Boom, Doom, Zoom! live show | 20 August 2026: CSL, WTC, HUB and more!
Peter Switzer and Paul Rickard take your questions live, and this week the viewer picks set the agenda:
Expert buy, hold and sell recommendations from our team of analysts.
Peter Switzer and Paul Rickard take your questions live, and this week the viewer picks set the agenda:
I examine how to time thematic ETFs and why electric vehicles may now be the megatrend worth buying.
What are the advantages of an equal-weighted ETF? Is the takeover of plumbing supplies group Reliance Worldwide (RWC) a “done deal”? Have the brokers raised their target prices for CSL following a better-than-expected result? When does BHP trade ex-dividend? Is it fully franked?
Michael Gable, Managing Director of Fairmont Equities, says the biggest oil and gas stock on the Australian market, Woodside Energy (WDS), is breaking out of consolidation and is on the cusp of a significant run higher.
Over the next two weeks we will get the earnings show and tell from a number of companies that have had shockers over the past year or so but recently they have been ‘forgiven’ or at least trusted to perform better than expected. Given the fact that many such as Xero, WiseTech, CSL and others have picked up a get-out-of jail card of late, these companies will need to deliver something positive, or at least not give any new bad news.
I have been a long-time fan of Telstra (TLS), not because it is a great company – because it is not – but because it is the dominant player providing services that none of us can go without. Further, as an investor, it is a super defensive stock which has reliable earnings, those earnings have been steadily increasing and it pays a good, almost fully franked dividend, which has also been increasing.
Raymond Chan of Morgans explains why Morgans' stock of the week is Treasury Wine Estates (TWE), reflecting improving momentum from the company's FY26 result.
It is a very esoteric niche on the ASX, but regenerative medicine is a fascinating area. ASX-listed companies PolyNovo, AVITA Medical and AROA Biosurgery all focus on regenerative medicine and soft-tissue repair, targeting severe burns, trauma and complex wounds, using active biological or structural reconstruction.
Nine upgrades and seventeen downgrades. For the week ending Friday, 14 August 2026 – the second week of the August reporting season – the seven brokers monitored by FNArena issued nine ratings upgrades and seventeen downgrades.
Every stock Ryan Stokes, Lauren Antonoff, Julia Lee, Michael Gable and Mark Wallace discussed on this week's Switzer Show, in their own words.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.